Literature DB >> 28976013

Brooke-Spiegler syndrome: focus on reflectance confocal microscopy findings of trichoepithelioma and flat cylindroma.

K Cüre1, E Kocatürk1, A E Koku Aksu2, T Yüksel1, C Leblebici3, S Özekinci4, Ö Özkaya5, E Değirmentepe1.   

Abstract

Brooke-Spiegler syndrome (BSS) is a rare, autosomal dominant disorder characterized by multiple adnexal tumours, especially trichoepitheliomas, cylindromas and occasionally spiradenomas. These lesions usually begin to appear in the second or third decade of life. Malignant transformation of pre-existing tumours may occur. In vivo reflectance-mode confocal microscopy (RCM) is a noninvasive method that can be used to visualize the epidermis and the upper dermis at almost histological resolution. It has been used to evaluate several skin conditions, especially malignant lesions, and has been reported to be useful for differentiating between malignant and benign skin tumours. Only a few studies have reported on the use of confocal microscopy to characterize the features of benign adnexal neoplasms. We present a patient with BSS who presented to our clinic with multiple skin tumours. The possible utility of RCM for identifying adnexal neoplasms is emphasized in this report, which also describes the observed microscopic features.
© 2017 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2017        PMID: 28976013     DOI: 10.1111/ced.13223

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  2 in total

1.  Reflectance confocal microscopy of spiradenoma.

Authors:  Pedro Lobos; Constanza Lobos; Karol Baksai
Journal:  JAAD Case Rep       Date:  2022-05-06

2.  Significance of Dermoscopy in Association with Clinical Features in Differentiation of Basal Cell Carcinoma and Benign Trichoblastic Tumours.

Authors:  Martyna Sławińska; Anna Płaszczyńska; Joanna Lakomy; Krzysztof Pastuszak; Wojciech Biernat; Monika Sikorska; Roman J Nowicki; Michał Sobjanek
Journal:  Cancers (Basel)       Date:  2022-08-17       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.